Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV6 | Q9H1D0 | 4/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.44 |
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.44 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.44 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.44 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1507183 | 0.94 | TRPV6 (0.39) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL25376692 | 0.84 | TRPV6 (0.42) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL119711 | 0.81 | TRPV6 (0.39) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL10057608 | 0.81 | MGLL (0.44) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL8925345 | 0.80 | ENPP2 (0.46) | ENPP2CA4CA5ACA14CA5B | |
| SCHEMBL5952636 | 0.79 | TRPV6 (0.38) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL8515033 | 0.77 | TRPV6 (0.44) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL483731 | 0.77 | TRPV6 (0.45) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL26451 | 0.76 | TRPV6 (0.40) | TRPV6ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL691860 | 0.73 | ENPP2 (0.50) | TRPV6ENPP2ORAI1ORAI2ORAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005471-A | Novel method for synthesizing 4-tert-butyl biphenyl by using palladium to catalyze tetrafluorothianthrene salt | 内蒙古大学 | 2024-05-10 | — | — | CN | claimed |
| CN-122010899-A | Continuous flow preparation method of lenalidomide and derivatives thereof | 深圳连续制药科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12509480-B2 | Organometallic complex, light emitting diode, and electronic device | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-12-30 | — | — | US | disclosed |
| US-12065560-B2 | Propylene-ethylene random copolymer | LG CHEM, LTD. (KR) | 2024-08-20 | — | — | US | disclosed |
| CN-118005471-A | Novel method for synthesizing 4-tert-butyl biphenyl by using palladium to catalyze tetrafluorothianthrene salt | 内蒙古大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-117247362-B | Light conversion agent with asymmetric structure, light conversion adhesive film and preparation method thereof | 常州百佳年代薄膜科技股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| US-11858952-B2 | Compound and color conversion film comprising same | LG CHEM, LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| CN-112513051-B | Compound and color conversion film comprising the same | 株式会社LG化学 | 2023-12-26 | — | — | CN | disclosed |
| CN-117247362-A | Light conversion agent with asymmetric structure, light conversion adhesive film and preparation method thereof | 常州百佳年代薄膜科技股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| EP-3936542-B1 | PROPYLENE-ETHYLENE RANDOM COPOLYMER | LG CHEMICAL LTD (KR) | 2023-11-08 | — | — | EP | disclosed |
| US-6963017-B2 | Preparation of preparing substituted indanones | BASELL POLYOLEFINE GMBH (DE) | 2005-11-08 | — | — | US | disclosed |
| EP-0968158-B1 | METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM | BASELL POLYOLEFINE GMBH (DE) | 2005-08-10 | — | — | EP | disclosed |
| US-6916893-B2 | Polymerization-active transition metal complexes having bulky ligand systems | SER. V. GMBH (DE) | 2005-07-12 | — | — | US | disclosed |
| WO-2005058916-A2 | ORGANOMETALLIC TRANSITION METAL COMPOUND, BISCYCLOPENTADIENYL LIGAND SYSTEM, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2005-06-30 | — | — | WO | disclosed |
| US-20050059705-A1 | Aryl and heteroaryl compounds, compositions, and methods of use | VTVX HOLDINGS I LLC | 2005-03-17 | — | — | US | disclosed |
| WO-2005014533-A2 | ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | TRANSTECH PHARMA, INC. (US) | 2005-02-17 | — | — | WO | disclosed |
| US-20050033076-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2005-02-10 | — | — | US | disclosed |
| US-20040171774-A1 | Polymerization-active transition metal complexes having bulky ligand systems | RIEGER BERNHARD (DE) | 2004-09-02 | — | — | US | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
| EP-0832082-B1 | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ASTRAZENECA AB (SE) | 2001-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059705-A1 | Aryl and heteroaryl compounds, compositions, and methods of use | TFPI, F3, F2 | TRPV6 4377/4885ENPP2 71/4885ORAI1 4596/4885 |
| US-12509480-B2 | Organometallic complex, light emitting diode, and electronic device | GRK1, CRY1, NR2E3 | TRPV6 350/4885ENPP2 3768/4885ORAI1 1917/4885 |
| US-11858952-B2 | Compound and color conversion film comprising same | BLVRB, CDYL, CRY1 | TRPV6 4523/4885ENPP2 2784/4885ORAI1 4405/4885 |
| US-20050033076-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP2J2, IDH3A | TRPV6 4172/4885ENPP2 4721/4885ORAI1 4605/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | TRPV6 4133/4885ENPP2 4773/4885ORAI1 4577/4885 |
| US-20040171774-A1 | Polymerization-active transition metal complexes having bulky ligand systems | AP1M1, CCNC, CLTB | TRPV6 2917/4885ENPP2 4276/4885ORAI1 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.